Top 10 problems for pharmaceutical clinical operations consultants and how to fix them

Pharmaceutical clinical operations consultants play a crucial role in ensuring the successful completion of clinical trials and regulatory compliance. However, they often face several challenges that can hinder their effectiveness. Here, we will discuss the top 10 problems for pharmaceutical clinical operations consultants and how to fix them.

  1. Poor communication
  2. Lack of standardization
  3. Regulatory compliance
  4. Budget constraints
  5. Patient recruitment
  6. Data quality
  7. Site management
  8. Technology limitations
  9. Cultural and language barriers
  10. Time constraints

“Do not be afraid to take the role no one wants.”

Dannielle Appelhans Senior vice president of technical operations and chief technical officer at Novartis Gene Therapies

1. Poor communication

Communication is the key to success in any project, and clinical trials are no exception. Poor communication among team members can lead to delays, errors, and misinterpretation of data.

To fix this, clinical operations consultants should encourage open and transparent communication among team members, and establish regular check-ins to discuss progress, address issues, and provide updates.

Forbes has an excellent article with the help of the Forbes Coaching Council on 15 Common Leadership Communication Problems (And How To Correct Them).

Here is an interesting resource for practicing and improving communications skills that uses online, in person, virtual, and even ChatGPT training. See also: 10 Communication Skills for Your Life and Career Success.

2. Lack of standardization

“If you think of standardization as the best that you know today, but which is to be improved tomorrow; you get somewhere.”

Henry Ford

Clinical trials involve multiple stakeholders, including investigators, sponsors, and regulatory bodies. Lack of standardization in study procedures, data collection, and reporting can lead to inconsistencies, inaccuracies, and delays.

To fix this, clinical operations consultants should ensure consistency and accuracy across all study sites by developing and implementing:

  • standardized protocols
  • procedures
  • data management systems.

Without a standard template, protocols in the same organization can vary substantially. Even with such a template, different people in an organization may write the same protocol differently. For example, the same entry criteria that may not need to be different across protocols might not be standardized. Also, when you have a site that is participating in two studies, differences in wording may sometimes lead to errors.

3. Regulatory compliance

“Many people who try to do big bold things in the world find out it’s not about the money or the technology: It’s about the regulatory hurdles that will try and stop you.”

Peter Diamandis

Pharmaceutical clinical trials are subject to strict regulatory requirements, and non-compliance can result in costly delays, fines, and legal consequences.

To fix this, clinical operations consultants should stay up-to-date on current regulations, implement robust quality control and assurance programs, and maintain accurate and complete documentation of all study activities.

It is good to ensure that study plans have been reviewed by regulatory experts. Also, audits by quality assurance experts can be helpful, especially if the timing allows correction of any important problems before it is too late in the course of the trial.

4. Budget constraints

“A budget is telling your money where to go instead of wondering where it went.”

John Maxwell

Clinical trials are expensive, and budget constraints can limit the scope and quality of the study.

To fix this, clinical operations consultants should develop a realistic budget that accounts for all study expenses, including personnel, equipment, and supplies, and monitor expenses closely to ensure they stay within the allocated budget.

5. Patient recruitment

Recruiting and retaining study participants can be a significant challenge, especially in rare diseases or in regions with limited access to healthcare.

To fix this, clinical operations consultants should work with investigators to develop effective recruitment strategies, including:

  • targeted advertising
  • patient advocacy groups
  • community outreach programs.

It’s also important to do your best to rigorously and realistically estimate potential enrollment in studies. More often it seems that the tendency is to over estimate enrollment rather than to find that you have more patients than expected. Investigator’s often put forward unrealistic enrollment estimates.

Investigators will usually know which advertising methods will work for their site, whether it is radio, online ads, or whatever.

Patient advocacy groups can be helpful in getting out the word about clinical trials. In some cases, too, you may be able to present at conferences of their members.

6. Data quality

“Garbage in, garbage out.”

Unknown, but first time in print may be Raymond J. Crowley, March 1963.

The quality of data collected during clinical trials is critical to the success of the study and the accuracy of the results.

To fix this, clinical operations consultants should implement rigorous data management systems and processes, including data validation, cleaning, and monitoring, to ensure the integrity and completeness of the data.

It is important to review protocol deviations and risks to studies on a regular basis to correct problems in the early stages.

7. Site management

“Leadership is unlocking people’s potential to become better.”

Bill Bradley

Clinical trials often involve multiple study sites, each with its own set of challenges and issues.

To fix this, clinical operations consultants should develop and implement a site management plan that includes regular site visits, training, and support for site staff, and effective communication channels between the study team and site personnel.

8. Technology limitations

Technology plays a critical role in clinical trials, from data collection to analysis and reporting. However, outdated or inadequate technology can lead to delays, errors, and inefficiencies.

To fix this, clinical operations consultants should invest in modern, state-of-the-art technology and infrastructure to support study activities, including electronic data capture systems, remote monitoring tools, and virtual collaboration platforms.

9. Cultural and language barriers

“A language is a freeway to a culture.”

Abhijit Naskar

Clinical trials are often conducted in multiple countries and regions, each with its own cultural and linguistic nuances.

To fix this, clinical operations consultants should work with local experts and translators to ensure effective communication and cultural sensitivity across all study sites.

10. Time constraints

Clinical trials are often subject to tight deadlines, and delays can have significant consequences, including missed market opportunities, regulatory delays, and increased costs.

To fix this, clinical operations consultants should develop and implement a realistic timeline that accounts for all study activities and potential roadblocks, and monitor progress closely to ensure the study stays on track.

Conclusion

Pharmaceutical clinical operations consultants face several challenges that can hinder the success of clinical trials. However, by implementing effective strategies and processes to address these challenges, clinical operations consultants can ensure the success of clinical trials.